Business Context and Reporting Period
Company: TherapeuticsMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 4, 2019
Item Reported: Item 7.01 Regulation FD Disclosure
This filing serves to furnish an investor update (Exhibit 99.1) to the public. The information is provided pursuant to Regulation FD and is not deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, nor is it incorporated by reference into other filings unless expressly stated.
Key Financial Metrics
The provided text does not contain specific financial data. This filing is a procedural disclosure referencing an attached presentation rather than a financial statement.
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
No material changes to financial performance or operations are detailed within the text of this Form 8-K. The filing solely announces the availability of an investor update presentation dated February 4, 2019.
Guidance, Outlook, and Risks
Management Commentary: The company is furnishing an investor update which may be used in future meetings with investors or analysts. The specific content of the outlook or guidance is contained in Exhibit 99.1, which is not included in the provided text.
Risks and Contingencies: The filing includes standard legal disclaimers stating that the information is not subject to the liabilities of Section 18 of the Exchange Act and is not incorporated by reference into Securities Act filings.
Investor Verification Checklist
- Review Exhibit 99.1 (TherapeuticsMD, Inc. presentation dated February 4, 2019) for actual financial metrics, strategic updates, and forward-looking statements.
- Verify if the investor update contains any new guidance or operational milestones not previously disclosed.
- Confirm the status of the company's emerging growth company designation (indicated as unchecked/not applicable in this filing).